Comparison of Two Multimodal Analgesia Regimens in Total Knee Arthroplasty

NCT03990038 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Recruitment problems making the study completion unlikely

Conditions

Postoperative Pain

Interventions

DRUG: Continuous perineural infusion of ropivacaine 0.2% 5 ml/h for 48 h
DRUG: Extended Release Capsule

Sponsor

Ciusss de L'Est de l'Île de Montréal